Fatty acid compositions of red blood cell phospholipids in children with autism

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

We compared the compositions of fatty acids including n-3, n-6 polyunsaturated fatty acids, trans- and cis-monounsaturated fatty acids, and saturated fatty acids in the red blood cell membranes of 40 children with autism (20 with early onset autism and 20 with developmental regression) and age-matched, 20 typically developing controls and 20 subjects with non-autistic developmental disabilities. The main findings include increased levels of eicosenoic acid (20:1n9) and erucic acid (22:1n9) in autistic subjects with developmental regression when compared with typically developing controls. In addition, an increase in 20:2n6 and a decrease in 16:1n7t were observed in children with clinical regression compared to those with early onset autism. Our results do not provide strong evidence for the hypothesis that abnormal fatty acid metabolism plays a role in the pathogenesis of autism spectrum disorder, although they suggest some metabolic or dietary abnormalities in the regressive form of autism.

Original languageEnglish (US)
Pages (from-to)215-221
Number of pages7
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Volume74
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

lissamine rhodamine B
Autistic Disorder
Phospholipids
Blood
Fatty Acids
Erythrocytes
Cells
Chemical analysis
Monounsaturated Fatty Acids
Cell membranes
Unsaturated Fatty Acids
Metabolism
Developmental Disabilities
Omega-3 Fatty Acids
Cell Membrane

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

@article{add3c720bd9046bda6a24f2aa3f9a710,
title = "Fatty acid compositions of red blood cell phospholipids in children with autism",
abstract = "We compared the compositions of fatty acids including n-3, n-6 polyunsaturated fatty acids, trans- and cis-monounsaturated fatty acids, and saturated fatty acids in the red blood cell membranes of 40 children with autism (20 with early onset autism and 20 with developmental regression) and age-matched, 20 typically developing controls and 20 subjects with non-autistic developmental disabilities. The main findings include increased levels of eicosenoic acid (20:1n9) and erucic acid (22:1n9) in autistic subjects with developmental regression when compared with typically developing controls. In addition, an increase in 20:2n6 and a decrease in 16:1n7t were observed in children with clinical regression compared to those with early onset autism. Our results do not provide strong evidence for the hypothesis that abnormal fatty acid metabolism plays a role in the pathogenesis of autism spectrum disorder, although they suggest some metabolic or dietary abnormalities in the regressive form of autism.",
author = "B. Bu and Paul Ashwood and Harvey, {Danielle J} and King, {I. B.} and {Van de Water}, {Judith A} and Lee-Way Jin",
year = "2006",
month = "4",
doi = "10.1016/j.plefa.2006.02.001",
language = "English (US)",
volume = "74",
pages = "215--221",
journal = "Prostaglandins Leukotrienes and Essential Fatty Acids",
issn = "0952-3278",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Fatty acid compositions of red blood cell phospholipids in children with autism

AU - Bu, B.

AU - Ashwood, Paul

AU - Harvey, Danielle J

AU - King, I. B.

AU - Van de Water, Judith A

AU - Jin, Lee-Way

PY - 2006/4

Y1 - 2006/4

N2 - We compared the compositions of fatty acids including n-3, n-6 polyunsaturated fatty acids, trans- and cis-monounsaturated fatty acids, and saturated fatty acids in the red blood cell membranes of 40 children with autism (20 with early onset autism and 20 with developmental regression) and age-matched, 20 typically developing controls and 20 subjects with non-autistic developmental disabilities. The main findings include increased levels of eicosenoic acid (20:1n9) and erucic acid (22:1n9) in autistic subjects with developmental regression when compared with typically developing controls. In addition, an increase in 20:2n6 and a decrease in 16:1n7t were observed in children with clinical regression compared to those with early onset autism. Our results do not provide strong evidence for the hypothesis that abnormal fatty acid metabolism plays a role in the pathogenesis of autism spectrum disorder, although they suggest some metabolic or dietary abnormalities in the regressive form of autism.

AB - We compared the compositions of fatty acids including n-3, n-6 polyunsaturated fatty acids, trans- and cis-monounsaturated fatty acids, and saturated fatty acids in the red blood cell membranes of 40 children with autism (20 with early onset autism and 20 with developmental regression) and age-matched, 20 typically developing controls and 20 subjects with non-autistic developmental disabilities. The main findings include increased levels of eicosenoic acid (20:1n9) and erucic acid (22:1n9) in autistic subjects with developmental regression when compared with typically developing controls. In addition, an increase in 20:2n6 and a decrease in 16:1n7t were observed in children with clinical regression compared to those with early onset autism. Our results do not provide strong evidence for the hypothesis that abnormal fatty acid metabolism plays a role in the pathogenesis of autism spectrum disorder, although they suggest some metabolic or dietary abnormalities in the regressive form of autism.

UR - http://www.scopus.com/inward/record.url?scp=33646491403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646491403&partnerID=8YFLogxK

U2 - 10.1016/j.plefa.2006.02.001

DO - 10.1016/j.plefa.2006.02.001

M3 - Article

C2 - 16581239

AN - SCOPUS:33646491403

VL - 74

SP - 215

EP - 221

JO - Prostaglandins Leukotrienes and Essential Fatty Acids

JF - Prostaglandins Leukotrienes and Essential Fatty Acids

SN - 0952-3278

IS - 4

ER -